Source link : https://newshealth.biz/health-news/spironolactone-fails-to-cut-serious-cardiac-events-in-end-stage-kidney-disease/
(MedPage Today) — Daily treatment with a mineralocorticoid receptor antagonist flopped for reducing serious cardiac events in kidney failure patients on maintenance dialysis, a randomized trial found. Among over 2,500 patients in the ACHIEVE… Source link : https://www.medpagetoday.com/meetingcoverage/era/115970 Author : Publish date : 2025-06-09 16:57:00 Copyright for syndicated content belongs to the linked Source.
The post Spironolactone Fails to Cut Serious Cardiac Events in End-Stage Kidney Disease first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-09 16:57:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8